BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20949643)

  • 1. First-trimester molecular prenatal diagnosis of a thanatophoric dysplasia.
    Delahaye S; Rosenblatt J; Costa JM; Bazin A; Bénifla JL; Jouannic JM
    Prenat Diagn; 2010 Dec; 30(12-13):1222-3. PubMed ID: 20949643
    [No Abstract]   [Full Text] [Related]  

  • 2. Early ultrasound suspect of thanatophoric dysplasia followed by first trimester molecular diagnosis.
    Giancotti A; Castori M; Spagnuolo A; Binni F; D'Ambrosio V; Pasquali G; Pizzuti A; Grammatico P
    Am J Med Genet A; 2011 Jul; 155A(7):1756-8. PubMed ID: 21671381
    [No Abstract]   [Full Text] [Related]  

  • 3. Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology.
    Tonni G; Azzoni D; Ventura A; Ferrari B; Felice CD; Baldi M
    Fetal Pediatr Pathol; 2010; 29(5):314-22. PubMed ID: 20704477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
    De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
    Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
    Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
    J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
    Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of common mutations of the FGFR3 gene causing thanatophoric dysplasia type I: two case reports.
    Yang Y; Liu YN; Li DZ
    Fetal Pediatr Pathol; 2012 Jun; 31(3):128-33. PubMed ID: 22414243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of thanatophoric dysplasia by 3-D helical computed tomography and genetic analysis.
    Tsutsumi S; Sawai H; Nishimura G; Hayasaka K; Kurachi H
    Fetal Diagn Ther; 2008; 24(4):420-4. PubMed ID: 18987480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of thanatophoric dysplasia: the early prenatal 2D and 3D sonographic findings and molecular confirmation of diagnosis.
    Wong HS; Kidd A; Zuccollo J; Tuohy J; Strand L; Tait J; Pringle KC
    Fetal Diagn Ther; 2008; 24(1):71-3. PubMed ID: 18504386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thanatophoric dysplasia: a case report.
    Jagun OE; Olusola-Bello MA; Adekanmbi AF; Jagun OO; Oduwole T
    Pan Afr Med J; 2020; 37():220. PubMed ID: 33520059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
    Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
    Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
    [No Abstract]   [Full Text] [Related]  

  • 12. Second-trimester molecular diagnosis of a heterozygous 742 --> T (R248C) mutation in the FGFR3 gene in a thanatophoric dysplasia variant following suspicious ultrasound findings.
    Chen CP; Chern SR; Wang W; Wang TY
    Ultrasound Obstet Gynecol; 2001 Mar; 17(3):272-3. PubMed ID: 11309183
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of thanatophoric dysplasia using clinical exome screening.
    Holub M; Sekowská M; Smetanová D; Koudová M; Sobolová K; Šinská A; Heřman H
    Ceska Gynekol; 2023; 88(5):376-379. PubMed ID: 37932055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities.
    Sahinoglu Z; Uludogan M; Gurbuz A; Karateke A
    Arch Gynecol Obstet; 2003 Nov; 269(1):57-61. PubMed ID: 14605823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type 1.
    Yang Y; Li DZ
    Fetal Diagn Ther; 2009; 26(2):90-2. PubMed ID: 19752524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA.
    Chitty LS; Khalil A; Barrett AN; Pajkrt E; Griffin DR; Cole TJ
    Prenat Diagn; 2013 May; 33(5):416-23. PubMed ID: 23408600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of early prenatal diagnosis of thanatophoric dysplasia with respect to obstetric management.
    Loong EP
    Eur J Obstet Gynecol Reprod Biol; 1987 Jun; 25(2):145-52. PubMed ID: 3301448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stippling: a first trimester marker for thanatophoric dysplasia type I.
    Beuke L; Koduri P; Martinez F; Weiner S
    Prenat Diagn; 2010 Dec; 30(12-13):1220-1. PubMed ID: 20954151
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotyping of the C742T mutation of the FGFR3 gene causing type 1 thanatophoric dysplasia by high-resolution melting analysis.
    Liu YN; Li R; Li DZ
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):186-8. PubMed ID: 20569165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis and molecular analysis of type 1 thanatophoric dysplasia.
    Li D; Liao C; Ma X
    Int J Gynaecol Obstet; 2005 Dec; 91(3):268-70. PubMed ID: 16214145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.